{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:01:49Z","timestamp":1767711709322,"version":"3.48.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K17430"],"award-info":[{"award-number":["JP20K17430"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03720"],"award-info":[{"award-number":["JP20H03720"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08528"],"award-info":[{"award-number":["JP22K08528"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","award":["Academic Development Fundseio Gijuku Fukuzawa Memorial Fund for the Advancement of Education"],"award-info":[{"award-number":["Academic Development Fundseio Gijuku Fukuzawa Memorial Fund for the Advancement of Education"]}],"id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","award":["Research"],"award-info":[{"award-number":["Research"]}],"id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","award":["Program for the Advancement of Next Generation Research Projects"],"award-info":[{"award-number":["Program for the Advancement of Next Generation Research Projects"]}],"id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","award":["Ushioda Memorial Doctoral Student Grant"],"award-info":[{"award-number":["Ushioda Memorial Doctoral Student Grant"]}],"id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-survival of motor neuron (SMN) antibodies have recently been identified in rheumatic and musculoskeletal diseases (RMDs), notably mixed connective tissue disease (MCTD). However, their immunological characteristics, prevalence, and clinical relevance beyond MCTD remain poorly understood. This study aimed to elucidate the clinical significance of anti-SMN antibodies in a wide spectrum of RMDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed anti-SMN antibodies and antibody-producing cells using Western blotting and immunofluorescence staining with recombinant SMN complexes. Serum anti-SMN antibody titers were measured using a recombinant SMN complex-bound magnetic bead assay in 906 serum samples from patients with 16 types of RMDs and healthy controls. Clinical associations and treatment responses were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Western blotting using patients\u2019 sera confirmed SMN-specific antibodies. Immunofluorescence staining identified anti-SMN antibody-producing plasma cells in an MCTD patient\u2019s lymph node. Anti-SMN antibodies were detected in 36.7% of MCTD, 10.6% of systemic lupus erythematosus (SLE), and 2.4% of systemic sclerosis patients, while none of the healthy controls were positive. Antibody titers were higher against the SMN complex than individual components, highlighting the importance of the complex structure. In MCTD, antibody positivity was strongly correlated with interstitial lung disease (90.9% vs. 36.8%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.013). In SLE, antibody-positive patients had significantly lower white blood cell counts and complement levels, higher anti-ds-DNA antibody titer, and higher prevalence of serositis (35.0% vs. 11.3%), gastrointestinal involvement (15.0% vs. 2.4%), nephritis (70.0% vs. 30.4%), and higher median SLE Disease Activity Index scores (19.5 vs. 5.0) compared to antibody-negative patients (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.05). Antibody titers decreased after treatment (\u2212\u200971.5% at 3 months,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.010) and increased upon relapse.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-SMN antibodies are prevalent in MCTD and SLE. Consistent with prior studies, their titers in MCTD were associated with distinct clinical features. Importantly, we newly demonstrate that in SLE, anti-SMN antibody levels correlate with immune complex\u2013related manifestations and disease activity, providing a novel and clinically significant insight. These findings highlight their potential as biomarkers for disease stratification, organ involvement, and monitoring disease progression in RMDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41232-025-00399-w","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T02:13:56Z","timestamp":1764641636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-survival of motor neuron antibodies in rheumatic and musculoskeletal diseases: prevalence, clinical associations, and biomarker potential, with novel insights into disease activity in SLE"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-9810","authenticated-orcid":false,"given":"Yuki","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-6595","authenticated-orcid":false,"given":"Masaru","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"399_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Jolla L, Gordon Gould CR, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148\u201359. https:\/\/doi.org\/10.1016\/0002-9343(72)90064-2.","journal-title":"Am J Med"},{"key":"399_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJM196803072781004","volume":"278","author":"PH Schur","year":"1968","unstructured":"Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968;278:533\u20138.","journal-title":"N Engl J Med"},{"key":"399_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08916930400022715","volume":"38","author":"P Migliorini","year":"2005","unstructured":"Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005;38:47\u201354. https:\/\/doi.org\/10.1080\/08916930400022715.","journal-title":"Autoimmunity"},{"key":"399_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/art.30349","volume":"63","author":"M Satoh","year":"2011","unstructured":"Satoh M, Chan JYF, Ross SJ, Ceribelli A, Cavazzana I, Franceschini F, et al. Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins. Arthritis Rheum. 2011;63:1972\u20138. https:\/\/doi.org\/10.1002\/art.30349.","journal-title":"Arthritis Rheum"},{"key":"399_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/s0092-8674(00)81632-3","volume":"95","author":"L Pellizzoni","year":"1998","unstructured":"Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell. 1998;95:615\u201324. https:\/\/doi.org\/10.1016\/s0092-8674(00)81632-3.","journal-title":"Cell"},{"key":"399_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2008.09.020","volume":"135","author":"A Chari","year":"2008","unstructured":"Chari A, Golas MM, Klingenh\u00e4ger M, Neuenkirchen N, Sander B, Englbrecht C, et al. An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs. Cell. 2008;135:497\u2013509. https:\/\/doi.org\/10.1016\/j.cell.2008.09.020.","journal-title":"Cell"},{"key":"399_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet. 1997;6:1205\u201314. https:\/\/doi.org\/10.1093\/hmg\/6.8.1205.","journal-title":"Hum Mol Genet"},{"key":"399_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003431","volume":"9","author":"H El Kamouni","year":"2023","unstructured":"El Kamouni H, Jalaledin DS, Albert A, Hoa S, Vo C, Bourr\u00e9-Tessier J, et al. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype. RMD Open. 2023;9:e003431. https:\/\/doi.org\/10.1136\/rmdopen-2023-003431.","journal-title":"RMD Open"},{"key":"399_CR9","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/rheumatology\/kead341","volume":"63","author":"Y Todoroki","year":"2024","unstructured":"Todoroki Y, Satoh M, Kubo S, Kosaka S, Fukuyo S, Nakatsuka K, et al. Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease. Rheumatology (Oxford). 2024;63:1068\u201375. https:\/\/doi.org\/10.1093\/rheumatology\/kead341.","journal-title":"Rheumatology (Oxford)"},{"key":"399_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/rheumatology\/kex392","volume":"57","author":"A Amlani","year":"2018","unstructured":"Amlani A, Hazlewood GS, Hamilton L, Satoh M, Fritzler MJ. Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy. Rheumatology (Oxford). 2018;57:199\u2013200. https:\/\/doi.org\/10.1093\/rheumatology\/kex392.","journal-title":"Rheumatology (Oxford)"},{"key":"399_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","volume":"433","author":"I Cavazzana","year":"2016","unstructured":"Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, et al. Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods. 2016;433:1\u20135. https:\/\/doi.org\/10.1016\/j.jim.2016.02.017.","journal-title":"J Immunol Methods"},{"key":"399_CR12","unstructured":"Ministry of Health, Labor and Welfare, Japan. The Japanese clinical practice guidelines for mixed connective tissue disease. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000062437.html Accessed 16 April 2025."},{"key":"399_CR13","first-page":"288","volume":"29","author":"DafnaD Gladman","year":"2002","unstructured":"Gladman Dafna D, Ibanez Dominique, Urowitz Murray B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"399_CR14","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus for the OC-SELENA trial. N Engl J Med. 2005;353:2550\u20138. https:\/\/doi.org\/10.1056\/NEJMoa051135.","journal-title":"N Engl J Med"},{"key":"399_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"44","author":"DA Isenberg","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus. Rheumatology. 2005;44:902\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/keh624.","journal-title":"Rheumatology"},{"key":"399_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/s0021-9258(17)43698-2","volume":"259","author":"T Mimori","year":"1984","unstructured":"Mimori T, Hinterberger M, Pettersson I, Steitz JA. Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome. J Biol Chem. 1984;259:560\u20135. https:\/\/doi.org\/10.1016\/s0021-9258(17)43698-2.","journal-title":"J Biol Chem"},{"key":"399_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/annrheumdis-2020-218881","volume":"80","author":"N Kajio","year":"2021","unstructured":"Kajio N, Takeshita M, Suzuki K, Kaneda Y, Yamane H, Ikeura K, et al. Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling. Ann Rheum Dis. 2021;80:651\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218881.","journal-title":"Ann Rheum Dis"},{"key":"399_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/annrheumdis-2019-215862","volume":"79","author":"M Takeshita","year":"2020","unstructured":"Takeshita M, Suzuki K, Kaneda Y, Yamane H, Ikeura K, Sato H, et al. Antigen-driven selection of antibodies against SSA, SSB and the centromere complex\u2019, including a novel antigen, MIS12 complex, in human salivary glands. Ann Rheum Dis. 2020;79:150\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215862.","journal-title":"Ann Rheum Dis"},{"key":"399_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1265792","volume":"15","author":"M Takeshita","year":"2024","unstructured":"Takeshita M, Suzuki K, Nakazawa M, Kamata H, Ishii M, Oyamada Y, et al. Disease-specific autoantibody production in the lungs and salivary glands of anti-synthetase syndrome. Front Immunol. 2024;15:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2024.1265792.","journal-title":"Front Immunol"},{"key":"399_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102661","author":"M Takeshita","year":"2021","unstructured":"Takeshita M, Suzuki K, Nakazawa M, Kamata H, Ishii M, Oyamada Y, et al. Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease. J Autoimmun. 2021. https:\/\/doi.org\/10.1016\/j.jaut.2021.102661.","journal-title":"J Autoimmun"},{"key":"399_CR21","doi-asserted-by":"publisher","first-page":"26370","DOI":"10.1074\/jbc.M003299200","volume":"275","author":"WJ Friesen","year":"2000","unstructured":"Friesen WJ, Dreyfuss G. Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J Biol Chem. 2000;275:26370\u20135. https:\/\/doi.org\/10.1074\/jbc.M003299200.","journal-title":"J Biol Chem"},{"key":"399_CR22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M003299200","volume":"28","author":"H Koizumi","year":"2025","unstructured":"Koizumi H, Muro Y, Kamiya S, Akashi N, Yamashita Y, Ogawa-Momohara M, et al. Predictive value of anti-SMN complex antibodies for monitoring cardiopulmonary complications in MCTD: insights from an ELISA study using recombinant Gemin4 and an anti-nuclear antibody test. Int J Rheum Dis. 2025;28:e70089. https:\/\/doi.org\/10.1074\/jbc.M003299200.","journal-title":"Int J Rheum Dis"},{"key":"399_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.autrev.2005.10.012","volume":"5","author":"JD Reveille","year":"2006","unstructured":"Reveille JD. The genetic basis of autoantibody production. Autoimmun Rev. 2006;5:389\u201398. https:\/\/doi.org\/10.1016\/j.autrev.2005.10.012.","journal-title":"Autoimmun Rev"},{"key":"399_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, K\u00e4llberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis & Rheumatism. 2006;54:38\u201346. https:\/\/doi.org\/10.1002\/art.21575.","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"399_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaut.2008.04.009","volume":"31","author":"A Lleo","year":"2008","unstructured":"Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME. The consequences of apoptosis in autoimmunity. J Autoimmun. 2008;31(3):257\u201362. https:\/\/doi.org\/10.1016\/j.jaut.2008.04.009.","journal-title":"J Autoimmun"},{"key":"399_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020","volume":"6","author":"O Landon-Cardinal","year":"2020","unstructured":"Landon-Cardinal O, Baril-Dionne A, Hoa S, Meyer A, Leclair V, Bourr\u00e9-Tessier J, et al. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. 2020;6:e001357. https:\/\/doi.org\/10.1136\/rmdopen-2020.","journal-title":"RMD Open"},{"key":"399_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1191\/0961203305lu2187oa","volume":"14","author":"BL Man","year":"2005","unstructured":"Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus. 2005;14:822\u20136. https:\/\/doi.org\/10.1191\/0961203305lu2187oa.","journal-title":"Lupus"},{"key":"399_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/14397595.2014.933998","volume":"25","author":"H Watanabe","year":"2025","unstructured":"Watanabe H, Sugimoto M, Asano T, Sato S, Suzuki E, Takahashi A, et al. Relationship of complement activation route with clinical manifestations in Japanese patients with systemic lupus erythematosus: a retrospective observational study. Mod Rheumatol. 2025;25:205\u20139. https:\/\/doi.org\/10.3109\/14397595.2014.933998.","journal-title":"Mod Rheumatol"},{"key":"399_CR29","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3748\/wjg.v16.i24","volume":"16","author":"X-P Tian","year":"2010","unstructured":"Tian X-P, Zhang X, Lee T-Y. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol. 2010;16:2971\u20137. https:\/\/doi.org\/10.3748\/wjg.v16.i24.","journal-title":"World J Gastroenterol"},{"key":"399_CR30","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"22","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Mechanisms of disease systemic lupus erythematosus. N Engl J Med. 2011;22:2110\u201331. https:\/\/doi.org\/10.1056\/NEJMra1100359.","journal-title":"N Engl J Med"},{"key":"399_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.957303","volume":"13","author":"TM Sim","year":"2022","unstructured":"Sim TM, Mak A, Tay SH. Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: current understanding and future directions. Front Immunol. 2022;13:1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2022.957303.","journal-title":"Front Immunol"},{"key":"399_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","volume":"3","author":"O Unlu","year":"2016","unstructured":"Unlu O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016;3:75\u201384. https:\/\/doi.org\/10.5152\/eurjrheum.2015.0085.","journal-title":"Eur J Rheumatol"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-025-00399-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:57:41Z","timestamp":1767711461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41232-025-00399-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1186\/s41232-025-00399-w","relation":{},"ISSN":["1880-8190"],"issn-type":[{"type":"electronic","value":"1880-8190"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Keio University School of Medicine (approval number: 20130246) and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}